Food Allergy Clinical Trial
Official title:
Evaluation of Potential Allergenicity of New Wheat Varieties
The goal of the study is to determine accurate blood test levels that can predict whether or not subjects are truly allergic to certain foods. In this study, subjects that are clinically documented to be wheat-allergic will participate in a double blind oral food challenge. Blood will be collected from the subject to evaluate the potential allergenicity of proteins introduced into genetically modified crops and evaluate wheat-specific immunoglobulin-e (IgE) antibody reactivity to biotech and conventional wheat varieties.
The prevalence of food allergy is increasing in the pediatric population. A diagnosis of food
allergy carries significant medical, nutritional, and psychological implications for both
patients and their families. Therefore, making an accurate diagnosis is critical. However,
the diagnosis of symptomatic food allergy continues to be a challenge for allergists and
other practicing physicians. The patient's clinical history remains a key component in
diagnosing food allergy. Skin prick testing and food-specific immunoglobulin-e (IgE) testing
act as secondary tools to aid in the evaluation process, but these tests also suffer from a
high rate of false positivity. For specific IgE levels below the cutoffs to these foods,
however, supervised oral food challenges (OFCs) may be necessary to establish the diagnosis
of symptomatic food allergy, as the sensitivity of these values is relatively low. Currently,
the double-blind, placebo-controlled food challenge (DBPCFC) remains the gold standard for
the diagnosis of food allergy. OFCs have their own inherent drawbacks: they are not always
readily available to all patients, they are time-consuming, and they are potentially
dangerous due to their risk of anaphylaxis.
Wheat is one of the eight allergenic foods that are responsible for approximately 90% of all
food allergies. Wheat is less allergenic than other foods in this group and less likely to
cause multi-organ, severe, life-threatening reactions. Allergy to wheat is more prevalent in
children than adults and is considered a transient allergy of infancy/childhood. Wheat
allergy is often outgrown in early childhood, in most cases by age 3-5 years, but 35% show a
persistent allergy into adolescence. While previous studies using food-specific IgE
antibodies have determined diagnostic decision points that indicate a high likelihood of
clinical reactivity for certain foods, namely milk, egg, peanut, and fish, wheat-specific IgE
levels do not seem to be useful predictors of food challenge outcome, enabling reduction in
need for food challenges. Furthermore, false-positive IgE reactions to wheat and other
cereals are frequently seen in grass-allergic patients due to insignificant cross-reactivity
between water/salt-soluble proteins. Therefore, identification of wheat proteins associated
with symptoms to wheat is of importance.
Gliadins in particular have been implicated in allergy to wheat, both in IgE-mediatedallergy
and the non-IgE mediated celiac allergy. IgE antibodies to ω-5-gliadin have been found in
children with immediate reactions to ingested wheat, and published results show that
increased levels of IgE to ω-5-gliadin correlate with the outcome of food challenges. In a
Finnish study, all children with IgE antibodies to ω-5-gliadin reacted with immediate
symptoms to wheat challenges, while all patients with delayed or negative challenge test
results showed no detectable IgE antibodies to ω-5-gliadin.15 In a Japanese cohort, the
presence of elevated ω-5-gliadin-specific IgE antibodies was associated with immediate
symptoms with wheat food challenges and also in patients with a strong convincing history of
wheat allergy who were not challenged due to risk of anaphylaxis. Furthermore, patients with
severe reactions upon challenge had significantly higher levels of ω-5-gliadin-specific IgE
antibodies compared to children with mild or moderate symptoms. In a multicenter Japanese
study, Ebisawa et al. showed a significant relationship between the probability of wheat
allergy and the concentration of ω-5-gliadin-specific IgE antibodies with 2.6-fold increased
risk. In a study of mixed German and American subjects, ω-5-gliadin-specific IgE antibodies
did not correlate with food challenge outcomes in patients with suspected allergy. However,
the sample size in this study was much smaller than in others, and the German population
included more patients with non-IgE mediated wheat allergy with delayed symptoms, almost half
of the German cohort. Nonetheless, ω-5-gliadin-specific IgE antibodies may differ among
populations in Asia, Europe, and the United States due to dietary habits and genetics, and
further study is warranted, especially in a larger U.S. cohort.
Food crops that have been developed through agricultural biotechnology for commercial use are
thoroughly assessed for their safety. One of the key elements in the safety assessment of a
genetically improved crop is an evaluation of potential changes in their allergenic
properties. Allergenic properties of the crop can potentially be altered if a known allergen
or a protein that has high potential to become an allergen is introduced. In addition, the
level of expression of endogenous allergens might be altered as a result of transformation
and insertion of the new gene into the plant genome.
Since wheat is a known allergenic food crop, international guidelines require analyses to
determine if the introduction of the genes and production of the recombinant proteins in
wheat cause an unintended change in the levels of endogenous allergenic proteins. To address
this question, levels of wheat-specific IgE binding observed in the biotechnology derived
wheat varieties are compared to the set of binding values observed in reference wheat
varieties that are already on the market. Determining the levels of direct IgE binding using
an enzyme linked immuno-sorbent assay (ELISA) has been shown to be an appropriate method to
perform such comparisons, especially when the assay is validated and calibrated prior to the
production of data. This comparison is important as it will enable determinations of whether
there is heterogeneity in wheat-allergic patients with wheat allergy in terms of a
predominant trigger. Ultimately, crops may be engineered to eliminate culprit components if
predominant.
Food challenge outcomes and standard ImmunoCAP IgE assays to wheat will be compared to CRD
wheat testing in this study (Thermo Fisher Scientific, Waltham, MA). When evaluated together
with clinical history, skin test reactivity, and OFC outcomes, responses to individual
components may be able be used to predict food challenge responsiveness. With respect to
intact wheat-specific IgE levels, in two previous studies using these, a true 95% positive
predictive value cutoff to predict reactivity at OFC could not be determined to wheat,
although a physician challenge was suggested at an estimated wheat level of 26 kU/L to
determine possible reactivity.6,7 However, these studies are now over a decade old and
pre-dated component resolved diagnostics (CRD). CRD to major proteins ω-5-gliadin may prove
to be more beneficial in determining predictive levels of IgE and positive OFC outcomes to
wheat. Therefore, in addition to determining wheat component patterns that could predict OFC
outcomes, the investigators hope to determine 95% predictive decision points for each of the
individual components and compare these to the decision points estimated by the ImmunoCAP
assay to wheat.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03089476 -
Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy
|
N/A | |
Recruiting |
NCT05839405 -
Food Allergy in the Brain
|
||
Completed |
NCT02552537 -
iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions
|
Phase 4 | |
Completed |
NCT01634737 -
Crustacean Allergy and Dust Mites Sensitization
|
N/A | |
Recruiting |
NCT05521711 -
TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation
|
N/A | |
Completed |
NCT05072665 -
Fast Allergy Sensitivity Test
|
N/A | |
Active, not recruiting |
NCT04887441 -
Allergology: Information, Data and Knowledge Organization
|
||
Recruiting |
NCT03265262 -
The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy
|
N/A | |
Completed |
NCT04186949 -
Early Origins of Allergy and Asthma
|
||
Completed |
NCT02490007 -
Pertussis Immunisation and Food Allergy
|
||
Recruiting |
NCT03151252 -
Improvement of Foodallergy Diagnostic in Gastrointestinal Tract
|
N/A | |
Completed |
NCT02159833 -
Intranasal Diagnostics in Food Allergy: a Feasibility Study
|
N/A | |
Completed |
NCT02377284 -
Prevention and Management of Food Allergies
|
N/A | |
Completed |
NCT02354729 -
Encouraging Allergic Young Adults to Carry Epinephrine
|
N/A | |
Completed |
NCT02640560 -
One-year Survey of Anaphylaxis in Outpatient Children Allergic to Peanuts, Walnuts/Hazelnuts, Shellfish
|
N/A | |
Enrolling by invitation |
NCT06097572 -
Improved Diagnostics in Food Allergy Study
|
N/A | |
Recruiting |
NCT04606615 -
Skin Barrier Abnormalities and Oxidative Stress Response
|
||
Recruiting |
NCT05785299 -
Clinical Versus Home Introduction of Milk in Children With Non-IgE-mediated Cow's Milk Allergy
|
N/A | |
Not yet recruiting |
NCT06112873 -
Quality of Life in Food Allergy: Validation of Three Mini-questionnaires
|
||
Completed |
NCT03337802 -
Effect of Mediterranean Diet During Pregnancy on the Onset of Overweight and Obesity in the Offspring
|
N/A |